RxDoctor Payments Data

Robert Marks, MD

Pain Medicine · Austin, TXNPI 1447450796

Payments from drug & device makers

$15,089in general payments, 2019–2025

Across 363 payments — averaging $41.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$3K
  • Medtronic$3K
  • AbbVie$1K
  • Spinal Simplicity, LLC$651
  • Nalu Medical, Inc.$579
  • plus $4K from 33 others

What the payments were for

  • Travel & lodging$9016%
  • Food & beverage$14,17394%
  • Gifts$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,089 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$264,348
Medicare patients
313
Services billed
7,459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl43$26,087
NucyntaTapentadol Hcl24$25,347
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen549$16,399
Fentanyl56$8,644
Buprenorphine12$4,088
Oxycodone Hcl166$3,916
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen124$3,273
Morphine Sulfate ErMorphine Sulfate74$3,217
Celecoxib70$2,012
Lidocaine14$1,366
Hydromorphone Hcl65$1,327
Gabapentin47$1,305
Pregabalin45$1,061
Morphine Sulfate32$1,020
Duloxetine Hcl67$448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta$430$25,34724 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$17$5,10844 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 583 pain medicine providers in Texas.

Other pain medicine in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →